Perspectives

2:50
State of the art in CAR-T
Peter A. Riedell
4:10
MDS: state of the art in Europe
Valeria Santini
4:03
Managing unfit/frail MM patients
Daniele Derudas
2:06
Treatment approaches to CLL
Alessandra Ferrajoli
1:04
AA amyloidosis management
Luis Quintana
1:08
Next steps in multiple myeloma
Sagar Lonial
0:59
Successes of ERIC and the change to virtual congress
Paolo Ghia
1:28
Why young scientists should attend ERIC 2020
Kostas Stamatopoulos
2:31
The structure of ERIC 2020 and the workshops available
Paolo Ghia
1:54
Workshops on CLL and MRD at ERIC 2020
Kostas Stamatopoulos
0:59
The benefits of ERIC 2020 to young scientists
Paolo Ghia
2:17
Naval Daver on SOHO Italy 2020
Naval Daver
1:17
Overview of HSCT and GvHD at EBMT
Régis Peffault de Latour
1:06
Importance of collaboration in CAR-T
Alvaro Urbano
3:05
Amyloidosis classification and epidemiology
Joan Blade
5:43
Optimism for amyloidosis therapy
Joel Buxbaum
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals